Sales Support:
sales@worldwidemarketreports.com
U.S. :+1 415 871 0703
U.K. :+44-203-289-4040
AUS. : +61-2-4786-0457
INDIA :+91-848-285-0837
Menu Icon Close Icon
We have an updated report [Version - 2023] available. Kindly sign up to get the sample of the report.

Global AI-Enabled Drug Discovery and Clinical Trials Market by Component (Solutions and Services), By Solution (Data Aggregation and Analysis, Clinical Trials, Drug Design, Drug Characterization, Biomarker Research and Others), By Therapeutic Applications (Oncology, Cardiovascular Diseases, Nervous System Diseases, Respiratory Disorder, Metabolic Diseases, Immunologic Diseases, Infectious Diseases and Others), By End-User(Biopharmaceutical Industry, Contract Research Organizations (CROs), and Academic Institutes and Research Centers), and By Region (North America, Europe, Asia Pacific, South America, and Middle East & Africa), Forecast to 2020 to 2027

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Global AI-Enabled Drug Discovery and Clinical Trials market predicted to propel by the application of AI which improves the speed and precision of discovery and reduce timelines for drug discovery
Global AI-Enabled Drug Discovery and Clinical Trials market estimated to grow with a noteworthy rate during the forecast period, 2020-2027. It is due to AI helping companies in calculating vast patient datasets into digestible, tangible information, identifying personalized, precision medicine opportunities, or potential forecasting responses to new drugs. Additionally, the growing applications of AI to analyze the pool of potential subjects in drug discovery, analyzing the electronic medical reports of patients, and genomic data for improved clinical trial matching will contribute to the growth of AI-enabled drug discovery and clinical trials market. Moreover, the surge in the application of AI in drug discovery benefits from the open-source implementation will augment the global AI-enabled drug discovery and clinical trial market in the future time.
AI help in accelerating the treatments of rare diseases, identify potential rare diseases indications and predicts new indications for existing medicines. Further, growing adoption of Ai in the pharmacy industry for target discovery, compound synthesis, compound screening, crystal form prediction, patient recruitment, optimization of clinical trial design, and drug redirection will boom the AI-enabled drug discovery and clinical trials in the near future.
Components Overview in the Global AI-Enabled Drug Discovery and Clinical Trials Market
Based on components, the global AI-enabled drug discovery and clinical Trials market bifurcated into Solutions and Services. The Solutions segment likely to lead the market by 2027, attributable to AI, help in substantial implications in the development of biomarkers and detect the differences between healthy and cancerous tissues.
Solution Overview in the Global AI-Enabled Drug Discovery and Clinical Trials market
Based on the Solution, the global AI-Enabled drug discovery and clinical trials market classified into Data Aggregation and Analysis, Clinical Trials, Drug Design, Drug Characterization, Biomarker Research, and Others. The Drug Design segment estimated to gain a higher market share by 2017. It is due to AI, and Machine learning helps to discover and develop new drugs for chronic kidney disease and idiopathic pulmonary fibrosis.
Application Overview in the Global AI-Enabled Drug Discovery and Clinical Trials Market
Based on application, the global AI-Enabled Drug Discovery and Clinical Trials market classified into Oncology, Cardiovascular Diseases, Nervous System Diseases, Respiratory Disorder, Metabolic Diseases Immunologic Diseases, Infectious Diseases, and Others. The Oncology segment projected to register a higher CAGR by 2027, on account of the surge in demand for AI for improving the quality of care and patient outcomes and improve the accuracy of cancer diseases while minimizing damage to healthy organs at risk.
End-User Overview in the Global AI-Enabled Drug Discovery and Clinical Trials Market
Based on end-user, the global AI-enabled drug discovery and clinical trials market categorized into Biopharmaceutical Industry, Contract Research Organizations (CROs), and Academic Institutes and Research Centers. Biopharmaceutical Industry projected to lead the market by 2027, as a result of AI and machine learning help in manufacturing process improvement, identifying novel biological target, processing biomedical and clinical data, and detect diseases such as cancer.
Regional Overview in the Global AI-Enabled Drug Discovery and Clinical Trials Market
By geography, the Global AI-Enabled Drug Discovery and Clinical Trials Market segmented into North America, Asia Pacific, Europe, Middle East & Africa, and South America. North America accounted for a major share in 2019 and expected to dominate the market by 2027 the market as a result of the high focus on R&D & substantial investment in the healthcare sector by USA governments and the presence of globally leading pharmaceutical companies.
Global AI-Enabled Drug Discovery and Clinical Trials Market: Competitive Landscape
Companies such as Accutar Biotechnology Inc., AiCure, LLC, Ardigen, Atomwise, Inc, BenevolentAI, Berg LLC, Berkeley Lights, Inc., Biovista Inc, BioAge Labs, Inc., C4X Discovery Holdings Plc, Clinithink Ltd, Cloud Pharmaceuticals, Inc., Cyclica, Inc., CytoReason, and Symphony Innovation, LLC are the key players in the Global AI-Enabled Drug Discovery and Clinical Trials Market. 

Global AI-Enabled Drug Discovery and Clinical Trials Market
Report Content
1.	Research Strategic Development
1.1.	Market Modelling
1.2.	Product Analysis
1.3.	Market Trend and Economic Factors Analysis
1.4.	Market Segmental Analysis
1.5.	Geographical Mapping
1.6.	Country Wise Segregation
2.	Research Methodology
2.1.	Identification of Target Market
2.2.	Data Acquisition 
2.3.	Refining of Data/ Data Transformations
2.4.	Data Validation through Primary Techniques
2.5.	Exploratory Data Analysis
2.6.	Graphical Techniques/Analysis
2.7.	Quantitative Techniques/Analysis
2.8.	Visual Result/Presentation 
3.	Executive Summary
4.	Market Insights
4.1.	Economic Factor Analysis 
4.1.1.	Drivers
4.1.2.	Trends
4.1.3.	Opportunities
4.1.4.	Challenges
4.2.	Technological Landscape
4.3.	Competitors & Product Analysis
4.4.	Regulatory Framework
4.5.	Company market share analysis, 2019
4.6.	Porter's Five forces analysis
4.7.	New Investment Analysis
4.8.	PESTEL Analysis
5.	Global AI-Enabled Drug Discovery and Clinical Trials Market Overview
5.1.	Market Size & Forecast, 2016-2027
5.1.1.	Demand
5.1.1.1.	By Value (USD Million)
5.2.	Market Share & Forecast, 2016-2027
5.2.1.	By Component 
5.2.1.1.	Solutions
5.2.1.2.	Services
5.2.2.	 By Solution
5.2.2.1.	Data Aggregation and Analysis
5.2.2.2.	Clinical Trials
5.2.2.3.	Drug Design
5.2.2.4.	Drug Characterization
5.2.2.5.	Biomarker Research
5.2.2.6.	Others
5.2.3.	By Application 
5.2.3.1.	Oncology
5.2.3.2.	Cardiovascular Diseases
5.2.3.3.	Nervous System Diseases
5.2.3.4.	Respiratory Disorder
5.2.3.5.	Metabolic Diseases
5.2.3.6.	Immunologic Diseases
5.2.3.7.	Infectious Diseases
5.2.3.8.	Others
5.2.4.	By End-User 
5.2.4.1.	Biopharmaceutical Industry
5.2.4.2.	Contract Research Organizations (CROs)
5.2.4.3.	Academic Institutes and Research Centers
5.2.5.	By Region
5.2.5.1.	North America
5.2.5.2.	Europe
5.2.5.3.	Asia Pacific
5.2.5.4.	South America 
5.2.5.5.	Middle East & Africa 
6.	North America AI-Enabled Drug Discovery and Clinical Trials Market Overview
6.1.	North America AI-Enabled Drug Discovery and Clinical Trials Market Size & Forecast, 2016-2027
6.1.1.	Demand
6.1.1.1.	By Value (USD Million)
6.2.	North America AI-Enabled Drug Discovery and Clinical Trials Market Share & Forecast, 2016-2027
6.2.1.	By Component 
6.2.1.1.	Solutions
6.2.1.2.	Services
6.2.2.	 By Solution
6.2.2.1.	Data Aggregation and Analysis
6.2.2.2.	Clinical Trials
6.2.2.3.	Drug Design
6.2.2.4.	Drug Characterization
6.2.2.5.	Biomarker Research
6.2.2.6.	Others
6.2.3.	By Application 
6.2.3.1.	Oncology
6.2.3.2.	Cardiovascular Diseases
6.2.3.3.	Nervous System Diseases
6.2.3.4.	Respiratory Disorder
6.2.3.5.	Metabolic Diseases
6.2.3.6.	Immunologic Diseases
6.2.3.7.	Infectious Diseases
6.2.3.8.	Others
6.2.4.	By End-User 
6.2.4.1.	Biopharmaceutical Industry
6.2.4.2.	Contract Research Organizations (CROs)
6.2.4.3.	Academic Institutes and Research Centers
6.2.5.	By Country
6.2.5.1.	US
6.2.5.2.	Canada
6.2.5.3.	Mexico
6.2.6.	Company Market Share (Top 3-5)
6.2.7.	Economic Impact Study on North America AI-Enabled Drug Discovery and Clinical Trials Market 
7.	Europe AI-Enabled Drug Discovery and Clinical Trials Market Overview
7.1.	Europe AI-Enabled Drug Discovery and Clinical Trials Market Size & Forecast, 2016-2027
7.1.1.	Demand
7.1.1.1.	By Value (USD Million)
7.2.	Europe AI-Enabled Drug Discovery and Clinical Trials Market Share & Forecast, 2016-2027
7.2.1.	By Component 
7.2.1.1.	Solutions
7.2.1.2.	Services
7.2.2.	 By Solution
7.2.2.1.	Data Aggregation and Analysis
7.2.2.2.	Clinical Trials
7.2.2.3.	Drug Design
7.2.2.4.	Drug Characterization
7.2.2.5.	Biomarker Research
7.2.2.6.	Others
7.2.3.	By Application 
7.2.3.1.	Oncology
7.2.3.2.	Cardiovascular Diseases
7.2.3.3.	Nervous System Diseases
7.2.3.4.	Respiratory Disorder
7.2.3.5.	Metabolic Diseases
7.2.3.6.	Immunologic Diseases
7.2.3.7.	Infectious Diseases
7.2.3.8.	Others
7.2.4.	By End-User 
7.2.4.1.	Biopharmaceutical Industry
7.2.4.2.	Contract Research Organizations (CROs)
7.2.4.3.	Academic Institutes and Research Centers
7.2.5.	By Country
7.2.5.1.	Germany
7.2.5.2.	UK
7.2.5.3.	France
7.2.5.4.	Italy
7.2.5.5.	Rest of Europe
7.2.6.	Company Market Share (Top 3-5)
7.2.7.	Economic Impact Study on Europe AI-Enabled Drug Discovery and Clinical Trials Market 
8.	Asia Pacific AI-Enabled Drug Discovery and Clinical Trials Market Overview
8.1.	Asia Pacific AI-Enabled Drug Discovery and Clinical Trials Market Size & Forecast, 2016-2027
8.1.1.	Demand
8.1.1.1.	By Value (USD Million)
8.2.	Asia Pacific AI-Enabled Drug Discovery and Clinical Trials Market Share & Forecast, 2016-2027
8.2.1.	By Component 
8.2.1.1.	Solutions
8.2.1.2.	Services
8.2.2.	 By Solution
8.2.2.1.	Data Aggregation and Analysis
8.2.2.2.	Clinical Trials
8.2.2.3.	Drug Design
8.2.2.4.	Drug Characterization
8.2.2.5.	Biomarker Research
8.2.2.6.	Others
8.2.3.	By Application 
8.2.3.1.	Oncology
8.2.3.2.	Cardiovascular Diseases
8.2.3.3.	Nervous System Diseases
8.2.3.4.	Respiratory Disorder
8.2.3.5.	Metabolic Diseases
8.2.3.6.	Immunologic Diseases
8.2.3.7.	Infectious Diseases
8.2.3.8.	Others
8.2.4.	By End-User 
8.2.4.1.	Biopharmaceutical Industry
8.2.4.2.	Contract Research Organizations (CROs)
8.2.4.3.	Academic Institutes and Research Centers
8.2.5.	By Country
8.2.5.1.	China
8.2.5.2.	India
8.2.5.3.	Japan
8.2.5.4.	Australia
8.2.5.5.	Rest of Asia Pacific
8.2.6.	Company Market Share (Top 3-5)
8.2.7.	Economic Impact Study on Asia Pacific AI-Enabled Drug Discovery and Clinical Trials Market 
9.	South America AI-Enabled Drug Discovery and Clinical Trials Market Overview
9.1.	South America AI-Enabled Drug Discovery and Clinical Trials Market Size & Forecast, 2016-2027
9.1.1.	Demand
9.1.1.1.	By Value (USD Million)
9.2.	South America AI-Enabled Drug Discovery and Clinical Trials Market Share & Forecast, 2016-2027
9.2.1.	By Component 
9.2.1.1.	Solutions
9.2.1.2.	Services
9.2.2.	 By Solution
9.2.2.1.	Data Aggregation and Analysis
9.2.2.2.	Clinical Trials
9.2.2.3.	Drug Design
9.2.2.4.	Drug Characterization
9.2.2.5.	Biomarker Research
9.2.2.6.	Others
9.2.3.	By Application 
9.2.3.1.	Oncology
9.2.3.2.	Cardiovascular Diseases
9.2.3.3.	Nervous System Diseases
9.2.3.4.	Respiratory Disorder
9.2.3.5.	Metabolic Diseases
9.2.3.6.	Immunologic Diseases
9.2.3.7.	Infectious Diseases
9.2.3.8.	Others
9.2.4.	By End-User 
9.2.4.1.	Biopharmaceutical Industry
9.2.4.2.	Contract Research Organizations (CROs)
9.2.4.3.	Academic Institutes and Research Centers
9.2.5.	By Country
9.2.5.1.	Brazil
9.2.5.2.	Argentina
9.2.5.3.	Rest of South America
9.2.6.	Company Market Share (Top 3-5)
9.2.7.	Economic Impact Study on South America AI-Enabled Drug Discovery and Clinical Trials Market
10.	Middle East & Africa AI-Enabled Drug Discovery and Clinical Trials Market Overview
10.1.	Middle East & Africa AI-Enabled Drug Discovery and Clinical Trials Market Size & Forecast, 2016-2027
10.1.1.	Demand
10.1.1.1.	By Value (USD Million)
10.2.	Middle East & Africa AI-Enabled Drug Discovery and Clinical Trials Market Share & Forecast, 2016-2027
10.2.1.	By Component 
10.2.1.1.	Solutions
10.2.1.2.	Services
10.2.2.	 By Solution
10.2.2.1.	Data Aggregation and Analysis
10.2.2.2.	Clinical Trials
10.2.2.3.	Drug Design
10.2.2.4.	Drug Characterization
10.2.2.5.	Biomarker Research
10.2.2.6.	Others
10.2.3.	By Application 
10.2.3.1.	Oncology
10.2.3.2.	Cardiovascular Diseases
10.2.3.3.	Nervous System Diseases
10.2.3.4.	Respiratory Disorder
10.2.3.5.	Metabolic Diseases
10.2.3.6.	Immunologic Diseases
10.2.3.7.	Infectious Diseases
10.2.3.8.	Others
10.2.4.	By End-User 
10.2.4.1.	Biopharmaceutical Industry
10.2.4.2.	Contract Research Organizations (CROs)
10.2.4.3.	Academic Institutes and Research Centers
10.2.5.	By Country
10.2.5.1.	Saudi Arabia
10.2.5.2.	UAE
10.2.5.3.	South Africa
10.2.5.4.	Rest of Middle East & Africa
10.2.6.	Company Market Share (Top 3-5)
10.2.7.	Economic Impact Study on Middle East & Africa AI-Enabled Drug Discovery and Clinical Trials Market
11.	Competitor Analysis
11.1.	Company Description
11.2.	Financial Analysis
11.3.	Key Products
11.4.	Key Management Personnel 
11.5.	Contact Address
11.6.	SWOT Analysis
11.7.	Company Profile
11.7.1.	Accutar Biotechnology Inc.
11.7.2.	AiCure, LLC
11.7.3.	Ardigen
11.7.4.	Atomwise, Inc
11.7.5.	BenevolentAI
11.7.6.	Berg LLC
11.7.7.	Berkeley Lights, Inc.
11.7.8.	 BioAge Labs, Inc.
11.7.9.	Biovista Inc
11.7.10.	 C4X Discovery Holdings Plc
11.7.11.	Clinithink Ltd
11.7.12.	Cloud Pharmaceuticals, Inc.
11.7.13.	Cyclica, Inc.
11.7.14.	CytoReason,
11.7.15.	Symphony Innovation, LLC
11.7.16.	Other Prominent Players

Choose License Type

Happy To Assist You

Contact Images

We will be happy to help you find what you need. Please call us or write to us:

Frequently Asked Questions

This report incorporates the analysis of factors that augments the market growth. Report presents competitive landscape of the global market. This also provides the scope of different segments and applications that can potentially influence the market in the future. The analysis is based on current market trends and historic growth data. It includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xxx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by:
  • Product Types
  • Drug Class
  • Indication
  • Applications
  • Services Types
  • End-users
  • Distribution channel
  • Regions
The report share key insights on the following:
  • Current market size
  • Market forecast
  • Market opportunities
  • Key drivers
  • Restraints
  • Pipeline Analysis
  • Incidence Rate
  • Epidemiology Analysis
  • Prevalence rate
  • Regulatory scenario
  • Industry trend
  • Pestle Analysis
  • Porter’s Analysis
  • New product approvals/launch
  • Promotion and marketing initiatives
  • Pricing analysis
  • Export-import analysis
  • Trade analysis
  • Competitive landscape
It helps the businesses in making investments decisions.
Customization helps the organization to gain insight on specific segments and regions of interest. Thus, WMR offers tailored report information based on business requirement in order to take strategic calls.

Related Reports

Clinical Trial Simulation Tools Market Size And Share Analysis - Growth Trends And Forecasts ...
View More
Small Molecule Drug Design Software Market Size And Share Analysis - Growth Trends And Foreca...
View More
Protein Drug Screening Validation Database Market Size And Share Analysis - Growth Trends And...
View More
Cloud Based Drug Discovery Platform Market Size And Share Analysis - Growth Trends And Foreca...
View More
Cloud Computing In Clinical Trials Market Size And Share Analysis - Growth Trends And Forecas...
View More

Trusted Clients
A-T- Kearney.png
AbbVie.png
Agrinos.png
AIF-Metrics.png
Akzo-Nobel.jpg
Alfi-GMBH.png
Allergan.png
Almasra-Scientific-Bureau.jpg
ALPMA.jpg
Americana-Foods.png
ANP.png
Aptar-Group-Germany.jpg
asahi-kasei.png
ATC.png
atlas-servair.jpg
ATOS.png
Avalon.png
biofishency.png
biomx.png
borealisgroup.png
Cape-Peninsula.png
CBRE.png
Cennerv-Pharma.jpg
Clearponds.png
Compass-Group.png
Cortag-Industria.png
Covis-Pharma.jpg
DAIMLER-AG.jpg
Edipresse-Media.jpg
Epson.png
Evonik-Industries-AG.png
ExcelSource.png
Fingo.png
Firstkind.png
FLM-Foodingredients.png
Freudenberg.png
Fueltrax.jpg
Fugro-International.png
Fuji-Films.png
Funky-Sound-Studio.png
GALTWAY.png
Gartner.png
GBSC.png
Global-Information.jpg
Hanwha-Total-Petrochemical.png
Hebrew.png
Horiba-Mira.png
Hunter-and-Co-Investments.png
Hyosung.png
Hyssopus-Organics.jpg
IBSA.png
Ideagen.png
IMS.png
InSinkErator.png
Intas-Pharma.png
IntelMed-Sarl.png
Interdiligence-Consulting.png
Israel-Shopyards.png
Johnsons-Controls.png
kakaxi.jpg
KORDSA.png
kotra.png
KPMG.png
lantmannen.png
LEK.png
LG.jpg
Makuri-Technology.jpg
Mallinckrodt.png
Mappo.png
Maprimed.jpg
mcns.jpg
MED-EL.png
Mehr-Azin-Pouya-Sahand.png
Molkerei-Ammerland-eG.png
Monty-Holding.jpg
mpmaterials.png
Mundipharma.png
Nasco.png
Nitto.png
Nouryon.png
NOXTAK.png
Oskars.png
Paidotribo.png
Parnell-Pharmaceuticals.png
Podravka.png
ppg.png
Privi.png
Publicis Groupe.png
Qvetech.jpg
R3P.jpg
Samsung.png
Sapient.png
SEW-EURODRIVE.png
Shivananda.jpg
Silver-Clouds.png
SMIT.jpg
SOLVIAS.png
Spectrum.png
SR-Instruments-Oy.png
Star-Seed.png
Stryker -ENT.png
Synjenta.png
Terumo-Corp.png
TherOzone.png
Toshiba.png
TT-Electronics.png
umbc.edu.png
Vard.jpg
Vital-Xense.png
Walraven.png
Wlgore.png
Woodmac.png
WWF-UK.png
ZENOAQ.png
Zuellig-Pharma.png
Contact us

sales@worldwidemarketreports.com

mapicon
Sales Office (U.S.):
Worldwide Market Reports, 533 Airport Boulevard, Suite 400, Burlingame, CA 94010, United States

mapicon+1-415-871-0703

mapicon
Asia Pacific Intelligence Center (India):
Worldwide Market Reports, 403, 4th Floor, Bremen Business Center, Aundh, Pune, Maharashtra 411007, India.

phoneiconU.S. : +1 415 871 0703

phoneiconU.K. : +44-203-289-4040

phoneiconAUS. :+61-2-4786-0457

phoneiconIndia :+91-848-285-0837

Menu
Quick Links
Newsletter

Want us to send you latest updates of the current trends, insights, and more, signup to our newsletter (for alerts, special offers, and discounts).


Secure Payment By:
paymenticon

This website is secured Origin CA certificate on the server, Comodo, Firewall and Verified Sitelock Malware Protection

secureimg

© 2024 Worldwide Market Reports. All Rights Reserved